ERBB2 and breast cancer: As uncontrolled cell growth and survival are hallmarks of cancer37, we first tested the effects of AZD4547 on the proliferation of ErbB2-overexpressing MDA-MB-361, BT474, and SKBR3 breast cancer cell lines.